Atlas Trials

To Study the Effect of Aprocitentan on the Electrical Activity of the Heart in Healthy Men and Women

Clinical trial NCT04281342 · COMPLETED

Trial details

NCT number
NCT04281342
Sponsor
Idorsia Pharmaceuticals Ltd.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Healthy Subjects
Start date
2020-01-14
Primary completion
2021-08-03
Enrollment
48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.